| ALX | Amlexanox |
| AMOTL2 | angiomotin like-2 |
| BBB | blood brain barrier |
| BC | Breast Cancer |
| BZA | Bazedoxifene |
| CAR T | chimeric antigen receptor T cells modified |
| CNS | Central Nervous System |
| CSF-1 | colony stimulating factor-1 |
| CTGF | connective tissue growth factor |
| CTLs | cytotoxic T lymphocytes |
| Cyr61 | cysteine Rich angiogenic inducer 61 |
| D. | Drosophila |
| DDR | DNA damage response |
| Dox | Doxorubicin |
| DSBs | DNA double strand breaks |
| EGFR | epithelial growth factor receptor |
| EMT | epithelium-mesenchymal transition |
| FGF-1 | fibroblast growth factor |
| GBM | Glioblastoma |
| Hpo | Hippo |
| IDO | 3 dioxygenase |
| IKBKE | Inhibitor of nuclear factor Kappa-B Kinase |
| IR | Ionizing Radiation |
| LATS 1/2 | Large Tumor Suppressor homolog 1/2 |
| Mats | Mob As-Tumor-Suppressor |
| Mcp-1 | monocyte chemotactic protein 1 |
| miRNA | microRNA |
| MMPs | matrix metalloproteinases |
| MMR | mismatch repair |
| MOB1 A/B | Mps One Binder 1 |
| MST 1/2 | Mammalian Ste20-like 1 and 2 |
| NC | Nitidine chloride |
| PRCC | Papillary Renal Cell Carcinomas |
| NF2 | Neurofibromatosis type 2 |
| NRF2 | Nuclear Factor erythroid-derived 2-like 2 |
| NSCLC | Non-Small Cell Lung Cancer |
| PD-1 | programmed cell death protein-1 |
| PDAC | Pancreatic Ductal Adenocarcinoma |
| PD-L1 | programmed death-ligand 1 |
| PIP3 | PI-3-phosphate |
| RB | Retinoblastoma |
| Sav | Salvador |
| SERM | selective estrogen receptor modulator |
| TAMs | tumor associated macrophages |
| TAZ | Transcriptional Co-activator with PDZ-binding motif |
| TB | TEAD-Binding |
| TGF-b | Transforming Growth Factor beta |
| TMZ | Temozolomide |
| TPC | tumor promoting stem-like Characteristics |
| VPA | Valproic Acid |
| VP | Verteporfin |
| Wts | Warts |
| YAP | Yes-Associated Protein |
| Yki | Yorkie |